Abstract: The present technology generally provides biophotonic silicone membranes and methods useful in the management of scars. In particular, the biophotonic silicone membranes of the present technology are useful in preventing and/or treating post-surgical scar formation.
Abstract: The present disclosure relates to emissive polymeric matrices and methods of using them. The emissive polymeric matrices comprise a monomer such as, for example, 2-hydroxyehtyl methacrylate (HEMA) and at least one chromophore.
Abstract: The present document describes methods of use of photo activated compositions for oral disinfection and/or treatments which comprise at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmacologically acceptable carrier.
Abstract: There is provided a wound healing composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin in association with a pharmaceutically acceptable carrier. In addition, a method of topically treating wounds using at least one oxidant and at least one photoactivator capable of activating the oxidant followed by illumination of said photosensitizer is disclosed.
Type:
Grant
Filed:
November 11, 2014
Date of Patent:
March 21, 2017
Assignee:
KLOX Technologies Inc.
Inventors:
Remigio Piergallini, Nikolaos Loupis, Francesco Bellini
Abstract: There is provided a skin rejuvenation composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmaceutically acceptable carrier.
Type:
Grant
Filed:
November 13, 2014
Date of Patent:
June 28, 2016
Assignee:
KLOX Technologies Inc.
Inventors:
Remigio Piergallini, Nikolaos Loupis, Francesco Bellini
Abstract: Disclosed herein are compositions that can rapidly evolve oxygen and/or activated oxygen generally including an oxidizing agent (e.g., a peroxide) and an activating agent that has an emission wavelength between about 400 nm and about 570 nm (e.g., Eosin B, Eosin Y, or Erythrosine B). Methods of employing these compositions to whiten teeth, and methods of making these compositions and kits that include some or part of the composition ingredients, are also described.
Abstract: The present disclosure provides cosmetic compositions and methods for using the cosmetic compositions. In particular, the cosmetic compositions of the present disclosure include one or more chromophore(s) in association with a dermatologically acceptable carrier. The cosmetic biophotonic compositions and the methods of the present disclosure are useful for skin rejuvenation and/or skin conditioning.
Type:
Application
Filed:
September 13, 2013
Publication date:
December 17, 2015
Applicant:
KLOX Technologies Inc.
Inventors:
Nikolaos Loupis, Remigio Piergallini, Lise Hébert
Abstract: Biophotonic compositions comprising a photoactivator, a calcium phosphate mineral, hyaluronic acid and optionally glucosamine are disclosed. Said compositions have utility in the augmentation, repair and/or regeneration of bone when used in conjunction with actinic light of a wavelength absorbed by the photoactivator.
Abstract: The present document describes methods of use of photo activated compositions for oral disinfection and/or treatments which comprise at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmacologically acceptable carrier.
Abstract: Disclosed herein are teeth whitening compositions generally including an oxidizing agent (e.g., a peroxide), and an activating agent that has an emission wavelength between about 400 nm and about 570 nm (e.g., Eosin B). Methods of employing these compositions to whiten teeth, methods of making these compositions and kits that include some or part of the composition ingredients, are also described.
Abstract: There is provided a skin rejuvenation composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmaceutically acceptable carrier.
Type:
Grant
Filed:
December 20, 2013
Date of Patent:
March 24, 2015
Assignee:
KLOX Technologies Inc.
Inventors:
Remigio Piergallini, Nikolaos Loupis, Francesco Bellini
Abstract: There is provided a wound healing composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin in association with a pharmaceutically acceptable carrier. In addition, a method of topically treating wounds using at least one oxidant and at least one photoactivator capable of activating the oxidant followed by illumination of said photosensitizer is disclosed.
Type:
Grant
Filed:
December 20, 2013
Date of Patent:
March 10, 2015
Assignee:
KLOX Technologies Inc.
Inventors:
Remigio Piergallini, Nikolaos Loupis, Francesco Bellini
Abstract: There is provided a skin rejuvenation composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmaceutically acceptable carrier.
Type:
Grant
Filed:
December 20, 2013
Date of Patent:
December 16, 2014
Assignee:
KLOX Technologies Inc.
Inventors:
Remigio Piergallini, Nikolaos Loupis, Francesco Bellini
Abstract: The present disclosure provides biophotonic materials and methods useful in phototherapy. In particular, the biophotonic materials of the present disclosure include a cohesive matrix, and at least one chromophore, wherein the at least one chromophore can absorb and emit light from within the biophotonic material. The biophotonic materials and the methods of the present disclosure are useful for promoting wound healing and skin rejuvenation, as well as treating acne and various skin disorders.
Abstract: The present document describes methods of use of photo activated compositions for oral disinfection and/or treatments which comprise at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmacologically acceptable carrier.
Abstract: There is provided a skin rejuvenation composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmaceutically acceptable carrier.
Type:
Application
Filed:
December 20, 2013
Publication date:
August 7, 2014
Applicant:
KLOX Technologies Inc.
Inventors:
Remigio Piergallini, Nikolaos Loupis, Francesco Bellini
Abstract: The present document describes methods of use of photo activated compositions for oral disinfection and/or treatments which comprise at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmacologically acceptable carrier.
Abstract: There is provided a skin rejuvenation composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmaceutically acceptable carrier.
Type:
Grant
Filed:
November 6, 2009
Date of Patent:
February 25, 2014
Assignee:
KLOX Technologies Inc.
Inventors:
Remigio Piergallini, Nikolaos Loupis, Francesco Bellini
Abstract: There is provided a skin rejuvenation composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmaceutically acceptable carrier.
Type:
Grant
Filed:
February 19, 2013
Date of Patent:
January 28, 2014
Assignee:
KLOX Technologies Inc.
Inventors:
Remigio Piergallini, Nikolaos Loupis, Francesco Bellini
Abstract: There is provided wound healing composition which comprises at least one oxidant, at least one photoactivator capable of actuating the oxidant and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin in association with a pharmaceutically acceptable carrier. In addition, a method of topically treating wounds using at least one oxidant and at least one photoactivator capable of activating the oxidant followed by illumination of said photosensitizer is disclosed.
Type:
Grant
Filed:
November 6, 2009
Date of Patent:
January 21, 2014
Assignee:
KLOX Technologies Inc.
Inventors:
Remigio Piergallini, Nikolaos Loupis, Francesco Bellini